Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 Jun 24 | ONCT Oncternal Therapeutics | Stock Options Common Stock | Grant | Acquire A | No | No | 8.1 | 2,200 | 17.82 k | 2,200 |
23 May 24 | DVAX Dynavax Technologies | Common Stock | Grant | Acquire A | No | No | 0 | 5,357 | 0.00 | 17,571 |
23 May 24 | DVAX Dynavax Technologies | Stock Option Common Stock | Grant | Acquire A | No | No | 11.85 | 22,500 | 266.63 k | 22,500 |
10 Oct 23 | ZYNE Zynerba Pharmaceuticals | Common Stock | Dispose U | No | No | 0 | 47,824 | 0.00 | 0 | |
10 Oct 23 | ZYNE Zynerba Pharmaceuticals | Common Stock | Dispose U | No | No | 0 | 27,954 | 0.00 | 47,824 | |
10 Oct 23 | ZYNE Zynerba Pharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.3501 | 71,736 | 25.11 k | 0 |
10 Oct 23 | ZYNE Zynerba Pharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 1.01 | 34,663 | 35.01 k | 0 |